Viewing Study NCT04116359


Ignite Creation Date: 2025-12-24 @ 2:33 PM
Ignite Modification Date: 2026-02-02 @ 10:10 PM
Study NCT ID: NCT04116359
Status: WITHDRAWN
Last Update Posted: 2020-09-28
First Post: 2019-10-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Testing of the Addition of a New Anti-cancer Drug, Molibresib, to Chemotherapy Treatment (Etoposide and Cisplatin) for Patients With NUT Carcinoma
Sponsor:
Organization:

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Phases:

Phases

Phase Brief Phase Text View
None PHASE1 View
None PHASE2 View
Observational Models:
Time Perspective List:
Who Masked List: